Daily Archives: July 14, 2020
Researchers develop COVID-19 mortality risk calculator
14 Jul, 2020 | 08:33h | UTCResearchers develop COVID-19 mortality risk calculator – News Medical
Original Study [Preprint]: COVID-19 Mortality Risk Assessment: An International Multi-Center Study – medRxiv
See Calculator: COVID Analytics
Related Commentary on Twitter
Our team developed and validated a new COVID-19 mortality risk score using data from 33 hospitals across four different countries. I am very proud of this international collaboration. The paper is now available on medrxiv: https://t.co/VGEPJYqbEf
— Agni Orfanoudaki (@AgniOrfanoudaki) July 10, 2020
Viewpoint: communicating science in the time of a pandemic
14 Jul, 2020 | 08:28h | UTCCommunicating Science in the Time of a Pandemic – JAMA
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
14 Jul, 2020 | 08:21h | UTCInvited Commentary: HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised? – The Lancet Global Health
Airborne transmission of SARS-CoV-2: theoretical considerations and available evidence
14 Jul, 2020 | 08:30h | UTCAirborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence – JAMA
Author Interview: How Is COVID-19 Transmitted?
Related: The debate over “airborne” coronavirus spread, explained – Vox
Perspective – “My patient caught Covid-19 twice. So long to herd immunity hopes”
14 Jul, 2020 | 08:19h | UTCMy patient caught Covid-19 twice. So long to herd immunity hopes. – Vox
A new understanding of herd immunity
14 Jul, 2020 | 08:23h | UTCA New Understanding of Herd Immunity – The Atlantic
ESC/EAPCI Expert consensus document on ischemia with non-obstructive coronary arteries
14 Jul, 2020 | 08:10h | UTC
Evidence-based medicine and COVID-19: what to believe and when to change
14 Jul, 2020 | 08:16h | UTC
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
14 Jul, 2020 | 08:17h | UTCA perspective on potential antibody-dependent enhancement of SARS-CoV-2 – Nature
Related Commentary on Twitter
The enhancement of disease by antibody-dependent mechanisms (ADE) looms as a/the major concern for #SARSCoV2 vaccines and neutralizing antibodies. A new @nature perspective, explainer, and details of what needs to be donehttps://t.co/0c1Nx92B6v pic.twitter.com/DoflhwpR9A
— Eric Topol (@EricTopol) July 13, 2020
Guideline executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections
14 Jul, 2020 | 08:11h | UTC
Podcast: Hospital addiction medicine for the hospitalist
14 Jul, 2020 | 08:09h | UTC
Meta: analysis: Interferon-γ release assays vs. tuberculin skin test for detection and management of latent tuberculosis infection
14 Jul, 2020 | 08:14h | UTC
Tue July 14 – 10 Stories of The Day!
14 Jul, 2020 | 08:35h | UTC
1 – Researchers develop COVID-19 mortality risk calculator – News Medical
Original Study [Preprint]: COVID-19 Mortality Risk Assessment: An International Multi-Center Study – medRxiv
See Calculator: COVID Analytics
2 – Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence – JAMA
Author Interview: How Is COVID-19 Transmitted?
Related: The debate over “airborne” coronavirus spread, explained – Vox
3 – Communicating Science in the Time of a Pandemic – JAMA
4 – A New Understanding of Herd Immunity – The Atlantic
Invited Commentary: HIV, tuberculosis, and malaria: how can the impact of COVID-19 be minimised? – The Lancet Global Health
6 – My patient caught Covid-19 twice. So long to herd immunity hopes. – Vox
7 – A perspective on potential antibody-dependent enhancement of SARS-CoV-2 – Nature
10 –COVID-19 Updates / 14 July 2020 Edition
14 July 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)